论文部分内容阅读
目的探讨不同病因导致的急性呼吸窘迫综合征(ARDS)患者的无创正压通气(NIPPV)治疗。方法 20例ARDS患者,分为原发性肺损伤组(9例)和继发性肺损伤组(11例),比较两组间的APACHEⅡ分值,NIPPV治疗前后动脉血pH值,氧合指数(PaO2/FiO2)、呼吸频率等。结果两组治疗前与治疗2h后的PaO2/FiO2、呼吸频率均有显著差异,两组间的APACHEⅡ分值无显著性差异。结论 NIPPV治疗ARDS安全、有效,可以首选。
Objective To investigate noninvasive positive pressure ventilation (NIPPV) in patients with acute respiratory distress syndrome (ARDS) caused by different etiologies. Methods Twenty patients with ARDS were divided into primary lung injury group (n = 9) and secondary lung injury group (n = 11). APACHE Ⅱ score, arterial blood pH value before and after NIPPV treatment, oxygenation index (PaO2 / FiO2), respiratory rate and so on. Results Before and 2h after treatment, the PaO2 / FiO2 and respiration rate were significantly different between the two groups. There was no significant difference in APACHEⅡ scores between the two groups. Conclusion NIPPV is safe and effective in the treatment of ARDS and may be the first choice.